文献速递角膜与眼表疾病青光眼

供体角膜内皮细胞成熟度及其对接受角膜移植的青光眼患者移植片存活的影响

Donor Corneal Endothelial Cell Maturity and Its Impact on Graft Survival in Glaucoma Patients Undergoing Corneal Transplantation.
PubMed 文献 · Am J Ophthalmol · 2024-02-01

这项前瞻性队列研究纳入17例有青光眼手术史和51例无青光眼手术史的患者,在2014年10月至2016年10月于日本京都Baptist Eye Institute接受角膜移植。通过细胞表面标志物评估供体角膜内皮细胞成熟度,发现高成熟度组移植片5年存活率100%,低成熟度组25%(P < .05)。

要点

  • 高成熟度供体角膜内皮细胞组5年移植片存活率为100%,低成熟度组为25%(P < .05)。
  • 术后36个月,青光眼滤过泡眼高成熟度组平均ECD为1197 ± 352 cells/mm2,低成熟度组为853 ± 430 cells/mm2。
  • 术后36个月,高成熟度组ECL为55.5% ± 13.9%,低成熟度组为67.7% ± 18.1%。

核心结论

  • 使用含成熟分化角膜内皮细胞的供体角膜移植片可使有青光眼手术史患者的移植片长期存活。

研究设计与样本

  • 前瞻性队列研究,纳入17例有青光眼手术史和51例无青光眼手术史的患者,于2014年10月至2016年10月在日本京都Baptist Eye Institute接受角膜移植。
  • 从供体角膜残余周边组织培养人角膜内皮细胞,用荧光激活细胞分选术检测细胞表面标志物(CD166+、CD44-/dull、CD24-、CD105-)评估细胞成熟度。
  • 采用Kaplan-Meier分析或卡方检验评估移植后角膜移植片成功存活率。

主要发现

  • 术后36个月,青光眼滤过泡眼高成熟度组平均ECD为1197 ± 352 cells/mm2,低成熟度组为853 ± 430 cells/mm2。
  • 术后36个月,高成熟度组ECL为55.5% ± 13.9%,低成熟度组为67.7% ± 18.1%。
  • Kaplan-Meier分析显示术后5年总存活率为45%,高成熟度组为100%,低成熟度组为25%(P < .05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine corneal graft survival via corneal endothelial cell density (ECD) and corneal endothelial cell loss (ECL) at 5 years post-transplantation in the eyes of patients with and without a history of undergoing glaucoma surgery according to the maturity of the donor corneal endothelial cells. DESIGN: Prospective cohort study. METHODS: This prospective cohort study included 17 patients with glaucoma and 51 patients without glaucoma who underwent Descemet's stripping automated endothelial keratoplasty or penetrating keratoplasty at the Baptist Eye Institute, Kyoto, Japan, between October 2014 and October 2016. Human corneal endothelial cells were cultured from residual peripheral donor cornea tissue, and the maturity of the cells was evaluated by cell surface markers (ie, CD166+, CD44-/dull, CD24-, and CD105-) using fluorescence-activated cell sorting. Kaplan-Meier analysis or the chi-square test was used to assess the rate of successful corneal graft survival post-transplantation. RESULTS: At 36 months postoperatively, the mean ECD and ECL in the glaucoma-bleb eyes were 1197 ± 352 cells/mm2 and 55.5% ± 13.9% in the high-maturity group and 853 ± 430 cells/mm2 and 67.7% ± 18.1% in the low-maturity group, respectively. Kaplan-Meier analysis revealed that at 5 years postoperatively, the overall rate of survival was 45%, that is, 100% in the high-maturity group and 25% in the low-maturity group (P < .05). CONCLUSIONS: The findings in this prospective cohort study revealed that the use of donor corneal grafts containing mature-differentiated corneal endothelial cells could maintain the survival of the transplanted graft for a long-term period, even in patients with a history of undergoing glaucoma surgery.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kitazawa K, Toda M, Ueno M, et al. Donor Corneal Endothelial Cell Maturity and Its Impact on Graft Survival in Glaucoma Patients Undergoing Corneal Transplantation. Am J Ophthalmol. 2024. PMID: 38307212. doi:10.1016/j.ajo.2024.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。